Dr. Matt Lunning

Amy Cheese, a Colorado teacher, celebrated 10 years in remission from blood cancer after volunteering for CAR T-cell therapy at the Fred and Pamela Buffett Cancer Center. This treatment re-engineered her own immune cells to fight lymphoma. The article noted that while this success is gratifying, medical experts emphasized that gene and cellular therapy remains an evolving field.

A Colorado teacher named Amy Cheese celebrated 10 years in remission from blood cancer after volunteering for a CAR T-cell therapy clinical trial at the Fred and Pamela Buffett Cancer Center. This advanced therapy re-engineers a patient’s own immune cells to fight against cancer, which doctors had previously considered a last resort. The article also noted that this new technology field is continually evolving.

Amy Cheese, a Colorado teacher who relocated to Nebraska, celebrated 10 years of remission from lymphoma after undergoing CAR T-cell therapy at the Fred and Pamela Buffett Cancer Center in Omaha. This therapy re-engineers a patient’s own immune cells to fight cancer. The process was described as a last resort for her treatment.